DYC1663-2 Search Results


e hsp 70  (R&D Systems)
94
R&D Systems e hsp 70
E Hsp 70, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/DYC1663-2/pmc08660587-79-23-26?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
e hsp 70 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
hsp70 elisa kit  (R&D Systems)
93
R&D Systems hsp70 elisa kit
Fig. 4. Treatment-dependent release of <t>HSP70</t> and treatment- and HPV-dependent release of HMGB1 of HNSCC cells. The supernatants of the tumor cells were collected 24 h after the last treatment for ELISA analyses of HSP70 (A) and HMGB1 (B). The concentrations in ng/ml per 1*106 cells are shown as stacked bars showing the mean with ±SD. A Kruskal-Wallis test with Dunn’s correction for multiple testing was calculated to compare the different treatment approaches versus the control. Non-measurable values were set to 0; *p < 0.05, **p < 0.01, ***p < 0.001, n ≥4.
Hsp70 Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/DYC1663-2/pm37857049-68-11-19?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
hsp70 elisa kit - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 4. Treatment-dependent release of HSP70 and treatment- and HPV-dependent release of HMGB1 of HNSCC cells. The supernatants of the tumor cells were collected 24 h after the last treatment for ELISA analyses of HSP70 (A) and HMGB1 (B). The concentrations in ng/ml per 1*106 cells are shown as stacked bars showing the mean with ±SD. A Kruskal-Wallis test with Dunn’s correction for multiple testing was calculated to compare the different treatment approaches versus the control. Non-measurable values were set to 0; *p < 0.05, **p < 0.01, ***p < 0.001, n ≥4.

Journal: Neoplasia (New York, N.Y.)

Article Title: Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells.

doi: 10.1016/j.neo.2023.100944

Figure Lengend Snippet: Fig. 4. Treatment-dependent release of HSP70 and treatment- and HPV-dependent release of HMGB1 of HNSCC cells. The supernatants of the tumor cells were collected 24 h after the last treatment for ELISA analyses of HSP70 (A) and HMGB1 (B). The concentrations in ng/ml per 1*106 cells are shown as stacked bars showing the mean with ±SD. A Kruskal-Wallis test with Dunn’s correction for multiple testing was calculated to compare the different treatment approaches versus the control. Non-measurable values were set to 0; *p < 0.05, **p < 0.01, ***p < 0.001, n ≥4.

Article Snippet: The assays were performed according to the manufacturer’s recommendations of the HSP70 ELISA kit (Human/Mouse/Rat Total HSP70/ HSPA1A ELISA, R&D Systems, Minneapolis, MN, USA) and the HMGB1 ELISA kit (Ibl International).

Techniques: Enzyme-linked Immunosorbent Assay, Control